drugset / Trial / NCT06746402
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety, tolerability, and pharmacokinetics (PK) of high dose of BMS-986278 in healthy participants and to assess the effect of BMS-986278 on the ECG intervals in healthy participants.
Timeline
- Start
- 2025-02-10
- Primary completion
- 2025-09-11
- Completion
- 2025-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Admilparant | Small molecule | — | — |
| Subject | Moxifloxacin | Small molecule | — | — |
Indications
No indication recorded.